Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury.

Fatty acid-binding protein (FABP) holds promise for early detection of tissue injury. This small protein (15kD) appears earlier in the blood than large proteins after cell damage. Combined its characteristics of high concentration tissue contents and low normal plasma values provide the possibility of a rapid rise above the respective reference values, and thus an early indication of the appearance of tissue injury. A general review was presented on the current status of different types of FABP for the detection of tissue injury in patients with myocardial injury, brain injury and also in athletes or horses with skeletal muscle injury. To take full advantage of the characteristics of the early marker FABP, rapid analysis is a crucial parameter. In this review, an overview of the development of immunoassay for the quantification of FABP in buffer, plasma or whole blood was outlined. The characteristics of different FABP immunosensors and immunotests were described. The feasibility of these immunoassays to be used in routine clinical practice and in emergency case was also discussed. Nowadays, the improved automated immunoassays (e.g. a microparticle-enhanced turbidimetric immunoassay), less time-consuming bedside immunosensors and immunotests (e.g. a one-step FABP lateral flow immunotest), are the main advance technology in point-of-care testing. With these point-of-care tests, the application of FABP as an early tissue injury marker has a great potential for many clinical purposes.

[1]  J. Storch,et al.  The fatty acid transport function of fatty acid-binding proteins. , 2000, Biochimica et biophysica acta.

[2]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[3]  Y. Kitaura,et al.  Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein. , 2001, Clinical biochemistry.

[4]  J. Mair.  Progress in myocardial damage detection: new biochemical markers for clinicians. , 1997, Critical reviews in clinical laboratory sciences.

[5]  J. Glatz,et al.  Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man , 1992, Molecular and Cellular Biochemistry.

[6]  R. D. De Boer,et al.  Relations between muscle soreness and biochemical and functional outcomes of eccentric exercise. , 1993, Journal of applied physiology.

[7]  J. Veerkamp,et al.  Histochemical localization of heart-type fatty-acid binding protein in human and murine tissues , 1995, Histochemistry and Cell Biology.

[8]  H. Morita,et al.  Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction. , 1993, International journal of cardiology.

[9]  O. Hommes,et al.  Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia. , 1997, Dementia and geriatric cognitive disorders.

[10]  J. Korf,et al.  On-line flow displacement immunoassay for fatty acid-binding protein. , 1998, Journal of immunological methods.

[11]  P Englebienne,et al.  Use of colloidal gold surface plasmon resonance peak shift to infer affinity constants from the interactions between protein antigens and antibodies specific for single or multiple epitopes. , 1998, The Analyst.

[12]  V. Arolt,et al.  S100B in brain damage and neurodegeneration , 2003, Microscopy research and technique.

[13]  W. A. Kaptein,et al.  The Responses of Fatty Acid-Binding Protein and Creatine Kinase to Acute and Chronic Exercise in Junior Rowers , 2003, Research quarterly for exercise and sport.

[14]  B. Romner,et al.  Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. , 2000, Journal of neurotrauma.

[15]  Reinhard Renneberg,et al.  Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein. , 2003, Journal of immunological methods.

[16]  W. Hermens,et al.  Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. , 1994, British heart journal.

[17]  J. Mair,et al.  Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein. , 1998, British journal of sports medicine.

[18]  J. Kaski,et al.  Myocardial damage : early detection by novel biochemical markers , 1998 .

[19]  A. Twijnstra,et al.  Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. , 2004, Clinical chemistry.

[20]  K. Kawamura,et al.  Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. , 1995, Journal of immunological methods.

[21]  M. Pelsers.  Fatty acid-binding protein as plasma marker for tissue injury , 2004 .

[22]  J. Korf,et al.  A continuous displacement immunoassay for human heart-type fatty acid-binding protein in plasma. , 2004, Journal of immunological methods.

[23]  W. Hermens,et al.  Fatty acid-binding proteins as plasma markers of tissue injury. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[24]  Manfred Herrmann,et al.  Release of Glial Tissue–Specific Proteins After Acute Stroke: A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein , 2000, Stroke.

[25]  A. Raabe,et al.  Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. , 1998, Stroke.

[26]  A. Muijtjens,et al.  Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. , 1999, Clinical chemistry.

[27]  D. van der Voort.  Development of an immunosensor for on-line continuous measurement of cardiac injury , 2003 .

[28]  K. Kawamura,et al.  Human Heart-Type Cytoplasmic Fatty Acid-Binding Protein (H-FABP) for the Diagnosis of Acute Myocardial Infarction. Clinical Evaluation of H-FABP in Comparison with Myoglobin and Creatine Kinase Isoenzyme MB , 2000, Clinical chemistry and laboratory medicine.

[29]  J H Keffer,et al.  Myocardial markers of injury. Evolution and insights. , 1996, American journal of clinical pathology.

[30]  R Renneberg,et al.  Surface investigations on the development of a direct optical immunosensor. , 1998, Biosensors & bioelectronics.

[31]  R. Renneberg,et al.  Early Diagnosis of Acute Myocardial Infarction Using Immunosensors and Immunotests , 2003 .

[32]  Anthony Turner,et al.  Advances in Biosensors 2 , 1991 .

[33]  M. Verbeek,et al.  Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases , 2003, Annals of clinical biochemistry.

[34]  F. Spener,et al.  Recombinant Human Heart-Type Fatty Acid-Binding Protein as Standard in Immunochemical Assays , 1998, Clinical chemistry and laboratory medicine.

[35]  R. Renneberg,et al.  Kinetic analysis of immunointeractions with covalently immobilized fatty acid-binding protein using a grating coupler sensor. , 1998, Journal of immunological methods.

[36]  G. J. van der Vusse,et al.  Cellular fatty acid-binding proteins: their function and physiological significance. , 1996, Progress in lipid research.

[37]  M. Verbeek,et al.  Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients , 2003, Brain Research Bulletin.

[38]  Reinhard Renneberg,et al.  Enzyme immunosensor for diagnosis of myocardial infarction , 1996 .

[39]  Jean-Charles Sanchez,et al.  Fatty Acid Binding Protein as a Serum Marker for the Early Diagnosis of Stroke , 2004, Molecular & Cellular Proteomics.

[40]  J. Gijn,et al.  Myoglobin is a sensitive marker of increased muscle membrane vulnerability , 1990, Journal of Neurology.

[41]  P. Clarkson,et al.  Muscle function after exercise-induced muscle damage and rapid adaptation. , 1992, Medicine and science in sports and exercise.

[42]  R. Renneberg,et al.  A superior early myocardial infarction marker , 2004, Zeitschrift für Kardiologie.

[43]  P. Nellen,et al.  Integrated optical input grating couplers as biochemical sensors , 1988 .

[44]  K. Thygesen,et al.  Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .

[45]  K. Wodzig,et al.  Monoclonal antibodies to human heart fatty acid-binding protein. , 1995, Journal of immunological methods.

[46]  T. Nakata,et al.  Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic and Prognostic Marker in Acute Coronary Syndrome , 2003, Cardiology.

[47]  G. J. van der Vusse,et al.  Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. , 1999, Circulation research.

[48]  L Graff,et al.  Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. , 2000, Clinical chemistry.

[49]  W. A. Kaptein,et al.  Continuous ultraslow microdialysis and ultrafiltration for subcutaneous sampling as demonstrated by glucose and lactate measurements in rats. , 1998, Analytical chemistry.

[50]  K. Haglid,et al.  Determination of S‐100 and Glial Fibrillary Acidic Protein Concentrations in Cerebrospinal Fluid After Brain Infarction , 1991, Stroke.

[51]  W. Lukosz,et al.  Sensitivity of integrated optical grating and prism couplers as (bio)chemical sensors , 1988 .

[52]  T. Takano,et al.  Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[53]  Miloslav Pravda,et al.  Development of a disposable immunosensor for the detection of human heart fatty-acid binding protein in human whole blood using screen-printed carbon electrodes. , 2002, Talanta.

[54]  C. McNeil,et al.  Multicenter evaluation of an amperometric immunosensor for plasma fatty acid-binding protein: an early marker for acute myocardial infarction. , 1999, Clinical biochemistry.

[55]  H. Naruse,et al.  Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. , 1997, Clinical chemistry.

[56]  G. J. van der Vusse,et al.  One-Step Enzyme-Linked Immunosorbent Assay (ELISA) for Plasma Fatty Acid-Binding Protein , 1997, Annals of clinical biochemistry.

[57]  G. Specchia,et al.  Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. , 2000, European heart journal.

[58]  W. Roos,et al.  Development of a rapid microparticle-enhanced turbidimetric immunoassay for plasma fatty acid-binding protein, an early marker of acute myocardial infarction. , 1998, Clinical chemistry.

[59]  Reinhard Renneberg,et al.  Sensing fatty acid binding protein with planar and fiber-optical surface plasmon resonance spectroscopy devices , 1996 .

[60]  P. Feindt,et al.  Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[61]  F. Spener,et al.  An immunosensor based on disposable electrodes for rapid estimation of fatty acid-binding protein, an early marker of myocardial infarction. , 1997, Biosensors & bioelectronics.

[62]  J. Maessen,et al.  Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. , 1995, Circulation.

[63]  J. Korf,et al.  Development of a displacement immunoassay for human heart-type fatty acid-binding protein in plasma: the basic conditions. , 2003, Biosensors & bioelectronics.

[64]  D. Hochstrasser,et al.  A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt‐Jakob disease , 2003, Proteomics.